The Contraceptives by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Contraceptives Market:
https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report

According to The Business Research Company’s Contraceptives , The contraceptives market size has grown strongly in recent years. It will grow from $26.2 billion in 2023 to $28.25 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to introduction of the birth control pill, increased awareness and education about contraception, legal and social changes promoting reproductive rights, global population control initiatives, increase in the use of generic and low-cost drugs and devices.

The contraceptives market size is expected to see strong growth in the next few years. It will grow to $38.02 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to growing focus on male contraceptives, increased access to contraception in developing countries, integration of digital health technologies in contraception, rising demand for long-acting reversible contraceptives (larcs), growing accessibility to over-the-counter drugs on the online platform. Major trends in the forecast period include technological advancements in contraceptive methods, shift towards non-hormonal and natural contraceptive methods, expansion of over-the-counter access to certain contraceptives, emphasis on user-friendly and discreet contraceptive options, integration of telemedicine in contraceptive counseling and prescriptions.

The rising frequency of sexually transmitted illnesses or diseases is driving the demand for contraceptives. Sexually transmitted diseases (STDs) are infections spread from one person to another through sexual interaction. The most typical contact occurs during anal, oral, and vaginal intercourse and they can spread through other close physical contact methods. Contraceptives are employed to manage the transmission of sexually transmitted diseases like herpes and HPV, primarily through skin-to-skin contact. For instance, in May 2023, according to the Minnesota Department of Health, a US-based state health agency of the State of Minnesota, primary and secondary syphilis cases climbed 19% in 2022, from 564 in 2021 to 676 in 2022. In 2022, 20 instances of congenital syphilis in babies were recorded. This represents a 42 % rise from 2021 when 14 cases of congenital syphilis were documented. Therefore, the increase in sexually transmitted illnesses or diseases is expected to boost the demand for contraceptives during the forecast period.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=6920&type=smp


The contraceptives market covered in this report is segmented –

1) By Product: Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, Intra-Uterine Devices
2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, 44 Years
3) By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, Other Distribution Channels

Technology advancement is a key trend gaining popularity in the contraceptive market. Digital Contraceptives are the latest trend in the contraceptives market. Digital Contraception is a way of tracking periods online to know which days are riskier for pregnancy. In March 2021, Clue, a Berlin-based femtech company, received FDA approval to market Clue Birth Control, all-digital contraception based on period monitoring data. The birth control function can identify when days are high or low risk for pregnancy by integrating user menstrual cycle data with Clue's prediction algorithm. Users can then adjust their habits to fit their risk tolerance. Clue recommends that users refrain from sex entirely or use another form of contraception, such as condoms, on high-risk days.

Major Players:

Merck & Co. Inc.
Bayer AG
Church & Dwight Co. Inc.
Cipla Inc.
Reckitt Benckiser Group plc
The contraceptives market report table of contents includes:

1. Executive Summary
2. Contraceptives Market Market Characteristics
3. Contraceptives Market Market Trends And Strategies
4. Contraceptives Market Market - Macro Economic Scenario
5. Global Contraceptives Market Market Size and Growth

.

.

.

31. Global Contraceptives Market Market Competitive Benchmarking
32. Global Contraceptives Market Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Contraceptives Market Market
34. Contraceptives Market Market Future Outlook and Potential Analysis
35. Appendix

Related Reports:

https://goodprnews.com/cancer-immunotherapy-market-size-and-scope-trends/
https://goodprnews.com/case-management-market-size/
https://topprnews.com/cancer-immunotherapy-market-growth/
https://topprnews.com/case-management-market-size/


Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]



Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model